治疗药物对胎儿生长限制的婴儿大脑发育的影响
Julie A Wixey1, Tegan A White2,3, Beth R Piscopo2,3
1UQ Centre for Clinical Research, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, Queensland, Australia.
The Journal of physiology
|January 28, 2026
概括
胎儿生长限制 (FGR) 影响胎儿大脑发育. 本综述检查了FGR的产前和产后药物治疗方法,评估它们对发育中的大脑和血脑屏障的影响.
科学领域:
- 神经科学是一个神经科学.
- 发展生物学 发展生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 胎儿生长限制 (FGR) 与大脑发育障碍和神经功能障碍有关.
- 胎盘缺乏FGR导致营养/氧气供应减少和胎儿血液动力学变化,包括大脑节约.
- 在FGR中,血脑屏障 (BBB) 可能表现出增加的透性,影响药物输送到胎儿大脑.
研究的目的:
- 审查FGR产前和产后药物治疗的实验证据.
- 评估这些疗法对胎儿大脑发育,结构和功能的影响.
- 突出了解药物对FGR大脑的影响的重要性.
主要方法:
- 在FGR模型中进行药物治疗的实验研究的文献综述.
- 对胎儿大脑体积,神经病理学和血脑屏障完整性的药物影响的分析.
- 对特定药物的检查:硫酸,西尔代纳菲尔酸盐,黑激素,伊布洛芬,纳米颗粒和细胞疗法.
主要成果:
- 在FGR中节省大脑改变大脑血流和BBB功能.
- 目前正在研究各种药物用于FGR的神经保护和增长改善.
- 这些药物对发育中的FGR大脑的特定影响的数据仍在进行表征.
结论:
- 了解药物对发育中的FGR大脑的影响对于治疗开发至关重要.
- 需要针对FGR的新疗法,但它们对大脑结构和功能的影响必须被彻底评估.
- 需要进一步的研究来描述药物治疗对FGR大脑健康的影响.
相关概念视频
Antipsychotic Drugs: Therapeutic Uses and Side Effects
825
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
825
Drug Dosing: Infants and Children
292
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
292
Therapeutic Drug Monitoring: Drug Analysis Methods
192
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
192
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
511
Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Most drugs undergo restrictive clearance, which is proportional to the...
511
Therapeutic Drug Monitoring: Affecting Factors
220
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
220
Therapeutic Drug Monitoring: Overview and Classification
341
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
341


